De Ruysscher, Dirk
Niedermann, Gabriele
Burnet, Neil G.
Siva, Shankar
Lee, Anne W. M.
Hegi-Johnson, Fiona
Article History
First Online: 21 February 2019
Change Date: 4 March 2019
Change Type: Correction
Change Details: In the version originally published, an incorrect version of Figure 1 was used. This has now been replaced.
Competing interests
: D.D.R. has served on advisory boards for AstraZeneca, Bristol-Meyers-Squibb, Celgene, Merck Serono/Pfizer and Genentech and has received research grants from Bristol-Meyers-Squibb and Boehringer Ingelheim. No personal fees were received, only fees to the institution. The remaining authors declare no competing interests.